Dianthus Therapeutics Inc
DNTH
Loading quote...
Financials
| 52Week High | 32.27 | 52Week Low | 13.37 |
| Beta | 1.46 | Current Ratio Annual | 15.22 |
| Current Ratio Quarterly | 13.12 | Market Cap | 670.16M |
| Net Profit Margin TTM | -2,364.11 | Operating Margin TTM | -2,676.56 |
| Price To Book | 2.21 | Price To Sales TTM | 138.06 |
| Quick Ratio Annual | 14.98 | Quick Ratio Quarterly | 12.82 |
| Return On Assets TTM | -32.72 | Return On Equity TTM | -34.72 |
| Return On Investment TTM | -34.72 | Revenue Growth Quarterly Yoy | -89.64 |
| Revenue Growth TTMYoy | 17.99 | Revenue Per Share TTM | 0.14 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 97 | 0 | 2 | 6 | 2 | 0 | 35.13M | $763.79M |
| Mar 31, 2025 | 100(+3%) | 16(+%) | 13(+550%) | 30(+400%) | 31(+1450%) | 20(+%) | 37.85M(+8%) | $686.36M(-10%) |
| Jun 30, 2025 | 104(+4%) | 15(-6%) | 14(+8%) | 28(-7%) | 41(+32%) | 14(-30%) | 39.11M(+3%) | $725.52M(+6%) |